More and more monoclonals are on the market, plus the equipment to produce them
This is a preview of subscription content, log in via an institution to check access.
Rights and permissions
About this article
Cite this article
Immunotech ideas. Nature 324, 284–288 (1986). https://doi.org/10.1038/324284a0
Issue Date:
DOI: https://doi.org/10.1038/324284a0
- Springer Nature Limited